PYR-41: A Selective Ubiquitin-Activating Enzyme Inhibitor...
2025-10-19
PYR-41, a selective E1 enzyme inhibitor, unlocks precision in dissecting protein degradation, NF-κB signaling, and immune modulation. Seamlessly integrate this tool to disrupt ubiquitin-proteasome pathways in apoptosis, inflammation, and cancer studies—backed by robust protocols, troubleshooting strategies, and translational insights.